Novel 5-Substituted-1H-tetrazole Derivatives as Potent Glucose and Lipid Lowering Agents.
Open Access
- 1 January 2002
- journal article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 50 (1), 100-111
- https://doi.org/10.1248/cpb.50.100
Abstract
A series of 5-(4-alkoxyphenylalkyl)-1H-tetrazole derivatives, containing an oxazole-based group at the alkoxy moiety, was prepared and their antidiabetic effects were evaluated in two genetically obese and diabetic animal models, KKAy mice and Wistar fatty rats. Syntheses were performed by cyclization of the corresponding nitriles reacting with azide compounds. A large number of the 5-(4-alkoxyphenylalkyl)-1H-tetrazoles showed potent glucose and lipid lowering activities in KKAy mice. In particular, 5-[3-[6-(5-methyl-2-phenyl-4-oxazolylmethoxy)-3-pyridyl]propyl]-1H-tetrazole had potent glucose lowering activity (ED25=0.0839 mg⋅kg−1⋅d−1), being 72 times more active than pioglitazone hydrochloride (ED25=6.0 mg⋅kg−1⋅d−1). This compound also showed strong glucose lowering (ED25=0.0873 mg⋅kg−1⋅d−1) and lipid lowering effects (ED25=0.0277 mg⋅kg−1⋅d−1) in Wistar fatty rats. The antidiabetic effects of this compound are considered to be due to its potent agonistic activity for peroxisome proliferator-activated receptor γ (PPARγ) (EC50=6.75 nM).Keywords
This publication has 28 references indexed in Scilit:
- Non‐insulin dependent diabetes mellitus: defects in insulin secretionEuropean Journal of Clinical Investigation, 1993
- Diabetes, Exercise, and AtherosclerosisDiabetes Care, 1992
- Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up studyThe Lancet, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Oral Hypoglycemic AgentsThe New England Journal of Medicine, 1989
- Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic AgentDiabetes, 1983
- Therapeutic approaches to reducing insulin resistance in patients with noninsulin-dependent diabetes mellitusThe American Journal of Medicine, 1983
- Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- A New Genetically Obese-Hyperglycemic Rat (Wistar Fatty)Diabetes, 1981
- General Survey of Diabetic Features of Yellow KK MiceEndocrinologia Japonica, 1970